Narrow search
Showing 1 - 10 of 5,643
Cover Image
Orphan drugs: pricing, reimbursement and patient access
Barak, Adam; Shankar Nandi, Jyoti - In: International Journal of Pharmaceutical and Healthcare … 5 (2011) 4, pp. 299-317
Purpose – This article aims to provide a description of principal aspects of policy and practice associated with orphan drugs and treatments of rare diseases, and give perspectives for 2011 on new and emerging approaches for addressing patient access. Design/methodology/approach –...
Persistent link: https://www.econbiz.de/10014795860
Cover Image
Employees' emotional reactions to customer deal requests
Gillison, Stephanie T.; Northington, William Magnus; … - In: Journal of marketing theory and practice 24 (2016) 2, pp. 147-165
Persistent link: https://www.econbiz.de/10011489599
Cover Image
Pricing strategy and moral hazard : copay coupons in pharmaceuticals
Lee, Chung-Ying - In: International journal of industrial organization 70 (2020), pp. 1-38
Persistent link: https://www.econbiz.de/10012586659
Cover Image
When discounts raise costs : the effect of copay coupons on generic utilization
Dafny, Leemore S.; Ody, Christopher; Schmitt, Matt - In: American economic journal : a journal of the American … 9 (2017) 2, pp. 91-123
Persistent link: https://www.econbiz.de/10011657068
Cover Image
Contracting over Pharmaceutical Formularies and Rebates
Ho, Katherine; Lee, Robin S. - National Bureau of Economic Research - 2024
manufacturers over menus of formulary-contingent rebate payments and then selects a formulary. We then estimate how formulary … predictions align with aggregate rebate data, and we find that allowing a PBM to place branded drugs on preferred and non …-preferred tiers can substantially increase negotiated rebate payments …
Persistent link: https://www.econbiz.de/10015056114
Cover Image
Positioning and negotiations : the case of pharmaceutical pricing
Grepperud, Sverre; Pedersen, Pål Andreas - In: European journal of political economy 62 (2020), pp. 1-13
Persistent link: https://www.econbiz.de/10012312066
Cover Image
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin; Schüßler, Sofia; Hammerschmidt, Thomas - In: The European journal of health economics : HEPAC ; … 21 (2020) 7, pp. 1049-1057
Persistent link: https://www.econbiz.de/10012489955
Cover Image
COVID-19 vaccines and the role of patents
Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491
Persistent link: https://www.econbiz.de/10012800211
Cover Image
The recent Coronavirus (COVID-19) pandemic : a review of issues for Indian pharmaceutical exports
Ahmed, Aaheli; Chakraborty, Debashis; Bhattacharyya, Ranajoy - In: Foreign trade review : FTR ; quarterly journal of … 55 (2020) 3, pp. 418-435
Persistent link: https://www.econbiz.de/10012254375
Cover Image
Are biopharmaceutical budget caps good public policy?
Goldman, Dana P.; Lakdawalla, Darius; Baumgardner, James R. - In: The Economists' voice 13 (2016) 1, pp. 27-42
Persistent link: https://www.econbiz.de/10011585711